Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri - PubMed (original) (raw)
. 2001 Apr 15;92(2):276-84.
doi: 10.1002/ijc.1174.
Affiliations
- PMID: 11291057
- DOI: 10.1002/ijc.1174
Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
R Klaes et al. Int J Cancer. 2001.
Abstract
Cytological screening for cervical cancer or its precursors using Papanicolaou's smear test (Pap test) has been highly efficient to reduce the morbidity and mortality of cervical cancer. However, evaluation of the Pap test relies on subjective diagnostic parameters and is affected by a high rate of false-positive and false-negative results. More objective diagnostic parameters to identify truly dysplastic or neoplastic cells in cervical smears as well as in cervical biopsy samples would therefore avoid insecurity for many patients and the high screening costs associated with repeated testing. Cervical dysplasia is induced by persistent infections through high-risk types of human papillomaviruses (HPVs). Outgrowth of dysplastic lesions is triggered by increasing expression of two viral oncogenes, E6 and E7, which both interact with various cell cycle-regulating proteins. Among these is the retinoblastoma gene product pRB, which is inactivated by E7. pRB inhibits transcription of the cyclin-dependent kinase inhibitor gene p16(INK4a). Increasing expression of the viral oncogenes in dysplastic cervical cells might thus be reflected by increased expression of p16(INK4a). In line with this hypothesis, we observed marked overexpression of p16(INK4a) in all cervical intraepithelial neoplasm (CIN) I lesions (n = 47) except those associated with low-risk HPV types (n = 7), all CIN II lesions (n = 32), all CIN III lesions (n = 60) and 58 of 60 invasive cervical cancers. In contrast, no detectable expression of p16(INK4a) was observed in normal cervical epithelium (n = 42), inflammatory lesions (n = 48) and low-grade cervical lesions (CIN I) associated with low-risk HPV types (n = 7). Dysplastic cells could also be identified in cervical smears using a specific p16(INK4a) monoclonal antibody. These data demonstrate that p16(INK4a) is a specific biomarker to identify dysplastic cervical epithelia in sections of cervical biopsy samples or cervical smears.
Copyright 2001 Wiley-Liss, Inc.
Similar articles
- p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M, Russell P, Dalrymple C, Wallman N, Angus G, Leong A, Carter J, Cheerala B. Dray M, et al. Pathology. 2005 Apr;37(2):112-24. doi: 10.1080/00313020500058607. Pathology. 2005. PMID: 16028838 - p16 INK4a and Ki67 expression in normal, dysplastic and neoplastic uterine cervical epithelium and human papillomavirus (HPV) infection.
Calil LN, Edelweiss MI, Meurer L, Igansi CN, Bozzetti MC. Calil LN, et al. Pathol Res Pract. 2014 Aug;210(8):482-7. doi: 10.1016/j.prp.2014.03.009. Epub 2014 Apr 4. Pathol Res Pract. 2014. PMID: 24793773 - p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N, Ring M, Killalea AG, Uhlmann V, O'Donovan M, Mulcahy F, Turner M, McGuinness E, Griffin M, Martin C, Sheils O, O'Leary JJ. Murphy N, et al. J Clin Pathol. 2003 Jan;56(1):56-63. doi: 10.1136/jcp.56.1.56. J Clin Pathol. 2003. PMID: 12499437 Free PMC article. - Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies.
Mulvany NJ, Allen DG, Wilson SM. Mulvany NJ, et al. Pathology. 2008 Jun;40(4):335-44. doi: 10.1080/00313020802035907. Pathology. 2008. PMID: 18446622 Review. - [Aspects of molecular pathogenesis of cervical cancer in establishing new tumor markers for early detection and diagnosis].
von Knebel Doeberitz M. von Knebel Doeberitz M. Zentralbl Gynakol. 2001 Apr;123(4):186-91. doi: 10.1055/s-2001-14775. Zentralbl Gynakol. 2001. PMID: 11370525 Review. German.
Cited by
- RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions.
de Vasconcelos PC, Freitas TR, de Araújo Lopes LV, Peixoto LR, Xavier MP, Cançado Figueiredo AC, Dias KL, de Oliveira JG, de Oliveira Salles PG, Vago AR, de Paula Sabino A, de Lima Rocha MG. de Vasconcelos PC, et al. Biomark Med. 2024;18(17-18):771-785. doi: 10.1080/17520363.2024.2394384. Epub 2024 Sep 10. Biomark Med. 2024. PMID: 39254347 - Aging promotes accumulation of senescent and multiciliated cells in human endometrial epithelium.
Loid M, Obukhova D, Kask K, Apostolov A, Meltsov A, Tserpelis D, van den Wijngaard A, Altmäe S, Yahubyan G, Baev V, Saare M, Peters M, Minajeva A, Adler P, Acharya G, Krjutškov K, Nikolova M, Vilella F, Simon C, Zamani Esteki M, Salumets A. Loid M, et al. Hum Reprod Open. 2024 Aug 12;2024(3):hoae048. doi: 10.1093/hropen/hoae048. eCollection 2024. Hum Reprod Open. 2024. PMID: 39185250 Free PMC article. - Sodium valproate affects the expression of p16INK4a and p21WAFI/Cip1 cyclin‑dependent kinase inhibitors in HeLa cells.
Rocha MA, Cardoso AL, Martins C, Mello MLS. Rocha MA, et al. Oncol Lett. 2024 Jul 11;28(3):432. doi: 10.3892/ol.2024.14563. eCollection 2024 Sep. Oncol Lett. 2024. PMID: 39049983 Free PMC article. - High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity.
Cabibi D, Giannone AG, Quattrocchi A, Lo Coco R, Formisano E, Porcasi R, Benfante V, Comelli A, Capra G. Cabibi D, et al. Int J Mol Sci. 2024 May 14;25(10):5354. doi: 10.3390/ijms25105354. Int J Mol Sci. 2024. PMID: 38791395 Free PMC article. - 3D Printing for Cancer Diagnosis: What Unique Advantages Are Gained?
Zhang Y. Zhang Y. ACS Mater Au. 2023 Aug 28;3(6):620-635. doi: 10.1021/acsmaterialsau.3c00046. eCollection 2023 Nov 8. ACS Mater Au. 2023. PMID: 38089653 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials